Platelet-Derived Growth Factor-B (PDGF-B) Induced by Hypoxia Promotes the Survival of Pulmonary Arterial Endothelial Cells through the PI3K/Akt/Stat3 Pathway
Author(s) -
Limin Li,
Mengyuan Xu,
Xiaoxia Li,
Chengfang Lv,
Xiaoqian Zhang,
Hongjuan Yu,
Mingwen Zhang,
Yueyue Fu,
Hongbin Meng,
Jin Zhou
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000369709
Subject(s) - protein kinase b , platelet derived growth factor receptor , pi3k/akt/mtor pathway , hypoxia (environmental) , biology , platelet derived growth factor , cancer research , stat3 , apoptosis , growth factor , microbiology and biotechnology , signal transduction , chemistry , biochemistry , receptor , organic chemistry , oxygen
Pulmonary arterial endothelial plexiform lesions are a basic pathological change associated with pulmonary vascular remodeling and are characterized by the formation of tumorlets as a result of over-growth of endothelial cells. Accumulating evidence suggests that platelet-derived growth factor (PDGF) participates in regulating the progression of pulmonary arterial hypertension. However, whether PDGF promotes the survival of pulmonary arterial endothelial cells (PAECs), as well as the specific molecular mechanisms that underlie its actions, remains unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom